DK1778677T3 - Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler - Google Patents
Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midlerInfo
- Publication number
- DK1778677T3 DK1778677T3 DK05781746.2T DK05781746T DK1778677T3 DK 1778677 T3 DK1778677 T3 DK 1778677T3 DK 05781746 T DK05781746 T DK 05781746T DK 1778677 T3 DK1778677 T3 DK 1778677T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds useful
- antidiuretic agents
- heterocyclic condensed
- condensed compounds
- antidiuretic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60289004P | 2004-08-20 | 2004-08-20 | |
| EP04104006A EP1627876A1 (en) | 2004-08-20 | 2004-08-20 | Heterocyclic condensed compounds useful as antidiuretic agents |
| PCT/EP2005/054081 WO2006018443A1 (en) | 2004-08-20 | 2005-08-18 | Heterocyclic condensed compounds useful as antidiuretic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1778677T3 true DK1778677T3 (da) | 2010-04-19 |
Family
ID=34929464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05781746.2T DK1778677T3 (da) | 2004-08-20 | 2005-08-18 | Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8063038B2 (da) |
| EP (2) | EP1627876A1 (da) |
| JP (1) | JP4705105B2 (da) |
| KR (1) | KR100877336B1 (da) |
| CN (1) | CN1968947A (da) |
| AT (1) | ATE457026T1 (da) |
| AU (1) | AU2005273875B2 (da) |
| CA (1) | CA2567782A1 (da) |
| CY (1) | CY1110619T1 (da) |
| DE (1) | DE602005019241D1 (da) |
| DK (1) | DK1778677T3 (da) |
| ES (1) | ES2339786T3 (da) |
| HK (1) | HK1100290A1 (da) |
| HR (1) | HRP20100250T1 (da) |
| IL (1) | IL178839A0 (da) |
| MX (1) | MX2007001861A (da) |
| NO (1) | NO20071476L (da) |
| PL (1) | PL1778677T3 (da) |
| PT (1) | PT1778677E (da) |
| RU (1) | RU2359969C2 (da) |
| SI (1) | SI1778677T1 (da) |
| WO (1) | WO2006018443A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| KR20100017766A (ko) | 2007-05-10 | 2010-02-16 | 에이엠알 테크놀로지, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤조-1,4-디아제핀 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 이의 용도 |
| ES2715926T3 (es) | 2008-06-16 | 2019-06-07 | Univ Tennessee Res Found | Compuestos para el tratamiento del cáncer |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| EP2307387B1 (en) | 2008-07-16 | 2013-11-20 | F. Hoffmann-La Roche AG | Novel heterocyclyl compounds for treatment of cardiovascular disease |
| WO2011005842A1 (en) | 2009-07-09 | 2011-01-13 | Gilead Sciences, Inc. | Anti-rsv compounds |
| JP2011057661A (ja) * | 2009-08-14 | 2011-03-24 | Bayer Cropscience Ag | 殺虫性カルボキサミド類 |
| WO2011109059A1 (en) | 2010-03-01 | 2011-09-09 | Gtx, Inc. | Compounds for treatment of cancer |
| US9119878B2 (en) | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| EP2612663A1 (en) * | 2012-01-04 | 2013-07-10 | Wellesley Pharmaceuticals, LLC | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| EP2612662B1 (en) * | 2012-01-04 | 2020-03-04 | Wellesley Pharmaceuticals, LLC | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| RU2597156C2 (ru) * | 2012-01-04 | 2016-09-10 | УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Состав с отсроченным высвобождением для уменьшения частоты мочеиспускания и способ его применения |
| KR20140108675A (ko) * | 2012-01-04 | 2014-09-12 | 웰즐리 파마슈티컬스 엘엘씨 | 배뇨 빈도를 감소시키기 위한 연장-방출형 제제 및 이의 사용 방법 |
| CA2866853A1 (en) * | 2012-03-19 | 2013-07-26 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| CN105189447B (zh) * | 2013-06-25 | 2017-12-05 | 组合化学工业株式会社 | 制造硝基苯化合物的方法 |
| CN106810508B (zh) * | 2017-01-05 | 2019-12-10 | 浙江农林大学暨阳学院 | 一种铁催化多组分反应合成苯并[1,4]-氧氮杂卓化合物的方法 |
| WO2019003433A1 (ja) | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | ベンゾアゼピン誘導体 |
| CN114853728B (zh) * | 2022-05-07 | 2023-11-07 | 四川制药制剂有限公司 | 一种富马酸伏诺拉生片及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0015601D0 (en) * | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
-
2004
- 2004-08-20 EP EP04104006A patent/EP1627876A1/en not_active Withdrawn
-
2005
- 2005-08-18 KR KR1020077002387A patent/KR100877336B1/ko not_active IP Right Cessation
- 2005-08-18 AT AT05781746T patent/ATE457026T1/de active
- 2005-08-18 AU AU2005273875A patent/AU2005273875B2/en not_active Ceased
- 2005-08-18 US US11/660,207 patent/US8063038B2/en not_active Expired - Fee Related
- 2005-08-18 DE DE602005019241T patent/DE602005019241D1/de active Active
- 2005-08-18 WO PCT/EP2005/054081 patent/WO2006018443A1/en active Application Filing
- 2005-08-18 EP EP05781746A patent/EP1778677B1/en active Active
- 2005-08-18 PL PL05781746T patent/PL1778677T3/pl unknown
- 2005-08-18 RU RU2007101237/04A patent/RU2359969C2/ru not_active IP Right Cessation
- 2005-08-18 ES ES05781746T patent/ES2339786T3/es active Active
- 2005-08-18 CN CNA2005800192975A patent/CN1968947A/zh active Pending
- 2005-08-18 JP JP2007526462A patent/JP4705105B2/ja not_active Expired - Fee Related
- 2005-08-18 MX MX2007001861A patent/MX2007001861A/es active IP Right Grant
- 2005-08-18 PT PT05781746T patent/PT1778677E/pt unknown
- 2005-08-18 SI SI200530930T patent/SI1778677T1/sl unknown
- 2005-08-18 CA CA002567782A patent/CA2567782A1/en not_active Abandoned
- 2005-08-18 DK DK05781746.2T patent/DK1778677T3/da active
-
2006
- 2006-10-24 IL IL178839A patent/IL178839A0/en unknown
-
2007
- 2007-03-19 NO NO20071476A patent/NO20071476L/no not_active Application Discontinuation
- 2007-08-01 HK HK07108386.8A patent/HK1100290A1/xx not_active IP Right Cessation
-
2010
- 2010-04-26 CY CY20101100370T patent/CY1110619T1/el unknown
- 2010-05-03 HR HR20100250T patent/HRP20100250T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8063038B2 (en) | 2011-11-22 |
| AU2005273875A1 (en) | 2006-02-23 |
| EP1778677A1 (en) | 2007-05-02 |
| EP1778677B1 (en) | 2010-02-03 |
| EP1627876A1 (en) | 2006-02-22 |
| RU2359969C2 (ru) | 2009-06-27 |
| ES2339786T3 (es) | 2010-05-25 |
| IL178839A0 (en) | 2007-03-08 |
| KR20070027761A (ko) | 2007-03-09 |
| HRP20100250T1 (hr) | 2010-06-30 |
| RU2007101237A (ru) | 2008-09-27 |
| CY1110619T1 (el) | 2015-04-29 |
| JP4705105B2 (ja) | 2011-06-22 |
| US20080234250A1 (en) | 2008-09-25 |
| CN1968947A (zh) | 2007-05-23 |
| MX2007001861A (es) | 2007-04-24 |
| ATE457026T1 (de) | 2010-02-15 |
| JP2008509972A (ja) | 2008-04-03 |
| WO2006018443A1 (en) | 2006-02-23 |
| KR100877336B1 (ko) | 2009-01-07 |
| NO20071476L (no) | 2007-03-19 |
| CA2567782A1 (en) | 2006-02-23 |
| PL1778677T3 (pl) | 2010-07-30 |
| PT1778677E (pt) | 2010-03-17 |
| DE602005019241D1 (de) | 2010-03-25 |
| HK1100290A1 (en) | 2007-09-14 |
| SI1778677T1 (sl) | 2010-09-30 |
| AU2005273875B2 (en) | 2009-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071476L (no) | Antidiuretiske midler. | |
| MA29135B1 (fr) | Potentialisateurs de recepteurs du glutamate | |
| EA200301073A1 (ru) | N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора | |
| CY1112914T1 (el) | Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης | |
| DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
| CR20140316A (es) | Derivados de indol como antagonistas receptores de s1p1 (divisional 10922) | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| CY1109015T1 (el) | Διφαινυλ ενωσεις χρησιμες ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| NO20026094L (no) | Kondenserte azepinderivater og deres anvendelse som antidiuretiske midler | |
| HRP20080529T3 (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
| CY1108880T1 (el) | Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
| EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
| ATE503755T1 (de) | Cgrp-rezeptorantagonisten | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| EA200400454A1 (ru) | Мускариновые агонисты | |
| ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
| EA200801139A1 (ru) | Композиция для аэрозольной ингаляции | |
| EA200701881A1 (ru) | 1,3-тиазол-5-карбоксамиды, используемые в качестве противораковых химиотерапевтических агентов | |
| TH76960A (th) | สารผสมการย้อมสีเส้นผม ซึ่งประกอบรวมด้วย สารประกอบ 2-(อะมิโน หรือซับสทิทิวเทดอะมิโน)-3-5- ซับสทิทิวเทด ฟีนอล และการใช้ของสารผสมเหล่านี้ | |
| SE0303419D0 (sv) | New use 11 |